In mice, TFAP2B deletion has been demonstrated to cause congenital polycystic kidney disease, and several point mutations in the TFAP2B coding region are associated with Char syndrome, a human autosomal dominant disorder16–18. The gene discussed is TFAP2B; the disease is Char syndrome.